Literature DB >> 18197421

Role of the Teflon deposit in the recurrence of vesicoureteral reflux.

Zsolt Oberritter1, Reka Somogyi, Zsolt Juhasz, Andrew B Pinter.   

Abstract

A relationship between the Teflon deposit, visible with ultrasound, and long-term success of subureteric Teflon injection (STING) treatment was investigated. The study included only those patients with primary vesicoureteral reflux (VUR), in whom the reflux had disappeared and the Teflon deposits were visible 6 weeks following STING treatment. Cessation of VUR was proven by voiding cysto-urethrography (VCUG) in 99 patients (143 ureters). Average follow-up time was 9 (4-12) years. Patients were divided into two groups: group I, deposits visible with ultrasound [deposit (+)], and group II, no visible deposits at the end of the follow-up period [deposit (-)]. Reflux recurrence, the occurrence of urinary tract infection (UTI), and pyelonephritis were investigated, and technetium scintigraphy scans were examined. The deposit (+) group included 43 patients (65 ureters), and the deposit (-) group contained 56 patients (78 ureters). In the deposit (+) group there were no recurrences of VUR; however, 17 recurrences were found in the deposit (-) group (P < 0.05). Dimercaptosuccinic acid (DMSA) scintigraphy scans and occurrence of UTI showed significant difference between the groups (P < 0.05). A close relationship was found between the disappearance of the Teflon deposit and the recurrence of VUR. Disappearance of the Teflon deposit and repeated bacteriuria is a warning sign of the recurrence of VUR; therefore, VCUG might be warranted for these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197421     DOI: 10.1007/s00467-007-0725-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Evolution of the treatment of vesicoureteral reflux in Spain.

Authors:  Jose M Moran Penco; Andre Gomez Fraile; Jorge Rodríguez Alarcon; Francisco Garcia Merino; Diego Vela; Santiago Sanjuán Rodriguez; Aldolfo Aransay Brantot
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

2.  Endoscopic correction of primary vesicoureteric reflux.

Authors:  B O'Donnell; P Puri
Journal:  Br J Urol       Date:  1986-12

3.  Endoscopic treatment of vesico-ureteral reflux: twelve years' experience.

Authors:  N Capozza; M Patricolo; A Lais; E Matarazzo; P Caione
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

Review 4.  Endoscopic correction of vesicoureteral reflux.

Authors:  P Puri
Journal:  Curr Opin Urol       Date:  2000-11       Impact factor: 2.309

5.  Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup.

Authors:  Boris Chertin; Eric Colhoun; Murugesh Velayudham; Prem Puri
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

6.  Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene.

Authors:  P Puri; C Granata
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

7.  Migration and granulomatous reaction after periurethral injection of polytef (Teflon).

Authors:  A A Malizia; H M Reiman; R P Myers; J R Sande; S S Barham; R C Benson; M K Dewanjee; W J Utz
Journal:  JAMA       Date:  1984 Jun 22-29       Impact factor: 56.272

Review 8.  Ten year experience with subureteric Teflon (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux.

Authors:  P Puri
Journal:  Br J Urol       Date:  1995-02

9.  Subureteric Teflon injection (STING). Results of a European survey.

Authors:  P Puri; G K Ninan; R Surana
Journal:  Eur Urol       Date:  1995       Impact factor: 20.096

10.  Endoscopic correction of vesico-ureteric reflux by subureteric Teflon injection: follow-up ultrasound and voiding cystography.

Authors:  N S Blake; E O'Connell
Journal:  Br J Radiol       Date:  1989-05       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.